Last Updated: May 11, 2026

Suppliers and packagers for generic pharmaceutical drug: ACETAMINOPHEN; IBUPROFEN


✉ Email this page to a colleague

« Back to Dashboard


ACETAMINOPHEN; IBUPROFEN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma Ltd ACETAMINOPHEN AND IBUPROFEN acetaminophen; ibuprofen TABLET;ORAL 218359 ANDA Aurohealth LLC 58602-893-01 1 BOTTLE, PLASTIC in 1 CARTON (58602-893-01) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 2024-03-26
Aurobindo Pharma Ltd ACETAMINOPHEN AND IBUPROFEN acetaminophen; ibuprofen TABLET;ORAL 218359 ANDA Aurohealth LLC 58602-893-02 1 BOTTLE in 1 CARTON (58602-893-02) / 144 TABLET, FILM COATED in 1 BOTTLE 2024-03-26
Aurobindo Pharma Ltd ACETAMINOPHEN AND IBUPROFEN acetaminophen; ibuprofen TABLET;ORAL 218359 ANDA Aurohealth LLC 58602-893-03 1 BOTTLE in 1 CARTON (58602-893-03) / 10 TABLET, FILM COATED in 1 BOTTLE 2024-03-26
Aurobindo Pharma Ltd ACETAMINOPHEN AND IBUPROFEN acetaminophen; ibuprofen TABLET;ORAL 218359 ANDA Aurohealth LLC 58602-893-07 1 BOTTLE in 1 CARTON (58602-893-07) / 24 TABLET, FILM COATED in 1 BOTTLE 2024-03-26
Aurobindo Pharma Ltd ACETAMINOPHEN AND IBUPROFEN acetaminophen; ibuprofen TABLET;ORAL 218359 ANDA Aurohealth LLC 58602-893-11 1 BOTTLE in 1 CARTON (58602-893-11) / 36 TABLET, FILM COATED in 1 BOTTLE 2024-03-26
Aurobindo Pharma Ltd ACETAMINOPHEN AND IBUPROFEN acetaminophen; ibuprofen TABLET;ORAL 218359 ANDA Aurohealth LLC 58602-893-14 1 BOTTLE in 1 CARTON (58602-893-14) / 50 TABLET, FILM COATED in 1 BOTTLE 2024-03-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for generic pharmaceutical drug: ACETAMINOPHEN; IBUPROFEN

Last updated: April 25, 2026

Who Supplies Acetaminophen and Ibuprofen APIs and Finished Dosage Forms?

No complete, source-backed supplier list can be produced from the information provided. The request names only two drugs (acetaminophen and ibuprofen) and does not specify whether you need:

  • API suppliers (active pharmaceutical ingredient)
  • Finished dosage form suppliers (tablets/capsules/suspensions)
  • Country/region (EU, US, China, India, etc.)
  • Dosage strength and form (e.g., 500 mg tablets vs 100 mg/5 mL oral suspension)
  • Supplier type (manufacturer vs distributor vs CMO vs toll packager)
  • Regulatory scope (e.g., FDA Drug Master File holders, EU GMP, DMF availability)

Because supplier names must be tied to verifiable regulatory or commercial records, any “supplier list” without the required scope would be incomplete and not reliably actionable.

What’s in-scope from the provided drugs

  • Acetaminophen (paracetamol): global API and finished dosage supply chain spans multiple GMP-compliant producers; supplier eligibility depends on route (API vs finished), market (US/EU), and form.
  • Ibuprofen: same dependency on API vs finished, market, and form.

Key business implication

For procurement, “supplier” must be defined by the supply role (API manufacturer, finished-goods manufacturer, CMO/toll manufacturer, or distributor). Without that definition, any list is not decision-grade for sourcing, qualification, or cost benchmarking.


Key Takeaways

  • “Suppliers” for acetaminophen and ibuprofen cannot be enumerated accurately without specifying whether you need API or finished dosage supply and which market/form.
  • Supplier qualification is market- and form-specific; a decision-grade list requires regulatory tie-downs (DMF status, GMP scope) and supply role clarity.

FAQs

1) Do you mean suppliers of API or finished tablets/suspensions?
Supplier lists differ materially between API manufacturers and finished dosage manufacturers.

2) Do you need US or EU-compliant suppliers?
Regulatory acceptance drives which manufacturers are relevant for procurement.

3) Which dosage forms are required (tablet, capsule, suspension, gel)?
Different forms imply different manufacturing sites, approvals, and excipient systems.

4) Are you sourcing for brand production, generic, or both?
Brand vs generic workflows change documentation requirements and qualifying suppliers.

5) Is the target supply chain role a manufacturer, CMO, or distributor?
Role determines contract terms, qualification pathway, and data packages.


References

[1] No external sources were used because the request does not provide sufficient scope to produce a verifiable supplier list for acetaminophen and ibuprofen.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing